Longtime liberal advocate to lead generics industry group

The Generic Pharmaceutical Association is about to get a new lead lobbyist: Ralph Neas, whom the New York Times characterizes as "a longtime advocate for liberal causes." Neas told the Times he's "anxious to tell" policy makers about the generics industry's efforts in controlling healthcare costs. Report

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.